Artificial Sight: Basic Research, Biomedical Engineering, and Clinical Advances

Humayun, Mark S. (Editor) / Weiland, James D. (Editor) / Chader, Gerald (Editor) / Greenbaum, Elias (Editor)

ISBN 10: 1441923829 / ISBN 13: 9781441923820

Edité par Springer New York, 2010

A propos de cet article

424 pages. 9.00x6.10x1.00 inches. In Stock. N° de réf. du vendeur zk1441923829

Détails bibliographiques

Titre : Artificial Sight: Basic Research, Biomedical...

Éditeur : Springer New York

Date d'édition : 2010

Reliure : Paperback

Etat : Brand New

A propos de ce titre

Synopsis :

Artificial sight is a frontier area of modern ophthalmology combining the multidisciplinary skills of surgical ophthalmology, biomedical engineering, biological physics, and psychophysical testing. Many scientific, engineering, and surgical challenges must be surmounted before widespread practical applications can be realized. The goal of Artificial Sight is to summarize the state-of-the-art research in this exciting area, and to describe some of the current approaches and initiatives that may help patients in a clinical setting.

The Editors are active researchers in the fields of artificial sight, biomedical engineering and biological physics. They have received numerous professional awards and recognition for their work. The artificial sight team at the Doheny Eye Institute, led by Dr. Mark Humayun, is a world leader in this area of biomedical engineering and clinical research.

Key Features

• Introduces and assesses the state of the art for a broad audience of biomedical engineers, biophysicists, and clinical researchers
• Describes advances in microelectronics, microfabrication, surgical implantation, and psychophysical testing of visual prostheses
• Outlines the promise of artificial sight and the challenges that must be met

À propos de l?auteur:

The Editors are active researchers in the fields of artificial sight, biomedical engineering and biological physics. They have received numerous professional awards and recognition for their work. The artificial sight team at the Doheny Eye Institute, led by Dr. Mark Humayun, is a world leader in this area of biomedical engineering and clinical research.